[go: up one dir, main page]

IS4366A - Rúmvönd aðferð til framleiðslu á kirnisleifahliðstæðum og salisýlatsalt af þeim - Google Patents

Rúmvönd aðferð til framleiðslu á kirnisleifahliðstæðum og salisýlatsalt af þeim

Info

Publication number
IS4366A
IS4366A IS4366A IS4366A IS4366A IS 4366 A IS4366 A IS 4366A IS 4366 A IS4366 A IS 4366A IS 4366 A IS4366 A IS 4366A IS 4366 A IS4366 A IS 4366A
Authority
IS
Iceland
Prior art keywords
preparation
nucleic acid
acid analogues
salicylate salts
bedding method
Prior art date
Application number
IS4366A
Other languages
English (en)
Other versions
IS1844B (is
Inventor
Leithead Hill Malcolm
Jonathan Whitehead Andrew
David Goodyear Michael
Owen Dwyer P.
Hornby Roy
Hallett Peter
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4366(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4366A publication Critical patent/IS4366A/is
Publication of IS1844B publication Critical patent/IS1844B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
IS4366A 1994-04-23 1996-09-27 Rúmvönd aðferð til framleiðslu á kirnisleifahliðstæðum og salisýlatsalt af þeim IS1844B (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process
PCT/EP1995/001503 WO1995029174A1 (en) 1994-04-23 1995-04-21 Process for the diastereoselective synthesis of nucleoside analogues

Publications (2)

Publication Number Publication Date
IS4366A true IS4366A (is) 1996-09-27
IS1844B IS1844B (is) 2003-01-30

Family

ID=27267157

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4366A IS1844B (is) 1994-04-23 1996-09-27 Rúmvönd aðferð til framleiðslu á kirnisleifahliðstæðum og salisýlatsalt af þeim

Country Status (29)

Country Link
US (2) US6051709A (is)
EP (1) EP0757684B1 (is)
JP (2) JP4056558B2 (is)
KR (1) KR100241842B1 (is)
CN (2) CN1151146C (is)
AP (1) AP704A (is)
AT (1) ATE181326T1 (is)
AU (1) AU696612B2 (is)
BG (1) BG62810B1 (is)
BR (1) BR9507499A (is)
CZ (1) CZ293827B6 (is)
DE (1) DE69510347T2 (is)
DK (1) DK0757684T3 (is)
EE (1) EE03442B1 (is)
ES (1) ES2133769T3 (is)
FI (1) FI120401B (is)
GR (1) GR3031043T3 (is)
HU (1) HU218044B (is)
IL (1) IL113432A (is)
IS (1) IS1844B (is)
NO (2) NO307179B1 (is)
NZ (1) NZ285396A (is)
PL (1) PL180090B1 (is)
RO (2) RO118714B1 (is)
RU (1) RU2158736C2 (is)
SK (1) SK281327B6 (is)
TW (1) TW487704B (is)
UA (1) UA43362C2 (is)
WO (1) WO1995029174A1 (is)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
US6034087A (en) * 1994-10-22 2000-03-07 Chong Kun Dang Corp. Nucleoside derivatives and process for preparing thereof
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
PT2322518E (pt) * 1998-08-12 2015-06-08 Gilead Sciences Inc Métodos de fabrico de nucleosídeos de 1,3-dioxolano e 1,3 oxatiolano
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
ES2299950T3 (es) 2001-03-01 2008-06-01 Abbott Laboratories Formas polimorficas y otras formas cristalinas cis-ftc.
US6600044B2 (en) 2001-06-18 2003-07-29 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) * 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
US20100190982A1 (en) * 2007-09-17 2010-07-29 Janardhana Rao Vascuri Process for the preparation of lamivudine form i
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
CN101918393A (zh) * 2007-11-29 2010-12-15 兰贝克赛实验室有限公司 拉米夫定的晶形i及其制备方法
BRPI0820224A2 (pt) * 2007-11-29 2015-06-16 Ranbaxy Lab Ltd Composto de fórmula iii ou seus estereoisômeros; processo para sua preparação e seu uso; uso de um composto de formula iii(a) ou iii(b) em um processo para a preparação de lamivudina de fórmula i(a) ou um composto de fórmula i(c); processo para preparação de lamivudina de fórmula i(a)
BRPI0820226A2 (pt) * 2007-11-29 2015-06-16 Ranbaxy Lab Ltd Processo para o preparo de um 1,3-oxatiolana, para o preparo de lamivudina e para isolar lamivudina, lamivudina e composição farmacêutica
US8350030B2 (en) * 2007-12-07 2013-01-08 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
US20110282046A1 (en) 2009-01-19 2011-11-17 Rama Shankar Process for preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
ES2540074T3 (es) 2009-10-14 2015-07-08 Mylan Laboratories Limited Proceso para la preparación de lamivudina y nuevas sales en la fabricación de la misma
PH12012501537A1 (en) 2010-01-27 2018-02-07 Viiv Healthcare Co Antiviral therapy
US20120295930A1 (en) 2010-02-03 2012-11-22 Shankar Rama Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) * 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
PL2542551T3 (pl) 2010-03-04 2015-01-30 Ranbaxy Laboratories Ltd Sposób stereoselektywnego otrzymywania 5-fluoro-1-(2R,SS)-[2-(hydroksymetylo)-1,3-oksatiolan--5-ylo]cytozyny
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
WO2012062835A1 (en) 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
EP2697238B1 (en) 2011-04-08 2019-03-20 Laurus Labs Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
AU3154993A (en) * 1989-02-08 1994-07-19 Biochem Pharma Inc. Process for preparing substituted 1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
AU1787492A (en) 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
JPH10502615A (ja) 1998-03-10
EE03442B1 (et) 2001-06-15
AP704A (en) 1998-12-04
CZ309696A3 (en) 1997-04-16
JP2007217425A (ja) 2007-08-30
US6051709A (en) 2000-04-18
EE9600134A (et) 1997-04-15
CN1151146C (zh) 2004-05-26
AP9600871A0 (en) 1996-10-31
BG62810B1 (bg) 2000-08-31
EP0757684A1 (en) 1997-02-12
ATE181326T1 (de) 1999-07-15
SK281327B6 (sk) 2001-02-12
PL180090B1 (pl) 2000-12-29
EP0757684B1 (en) 1999-06-16
IL113432A0 (en) 1995-07-31
FI964251L (fi) 1996-10-22
FI964251A0 (fi) 1996-10-22
JP4056558B2 (ja) 2008-03-05
HK1004221A1 (en) 1998-11-20
PL316904A1 (en) 1997-02-17
DE69510347D1 (de) 1999-07-22
SK135596A3 (en) 1997-07-09
DE69510347T2 (de) 1999-11-18
BR9507499A (pt) 1997-09-23
RU2158736C2 (ru) 2000-11-10
NO307179B1 (no) 2000-02-21
AU2447195A (en) 1995-11-16
HU218044B (hu) 2000-05-28
CN1290841C (zh) 2006-12-20
CZ293827B6 (cs) 2004-08-18
IL113432A (en) 2000-11-21
KR100241842B1 (ko) 2000-03-02
NO964487L (no) 1996-12-17
NO995646D0 (no) 1999-11-17
UA43362C2 (uk) 2001-12-17
HU9602925D0 (en) 1996-12-30
DK0757684T3 (da) 2000-01-17
IS1844B (is) 2003-01-30
NO995646L (no) 1999-11-17
CN1149871A (zh) 1997-05-14
HUT76296A (en) 1997-07-28
BG100916A (en) 1997-07-31
WO1995029174A1 (en) 1995-11-02
AU696612B2 (en) 1998-09-17
US6329522B1 (en) 2001-12-11
CN1500782A (zh) 2004-06-02
NZ285396A (en) 1998-10-28
ES2133769T3 (es) 1999-09-16
TW487704B (en) 2002-05-21
RO117916B1 (ro) 2002-09-30
NO313096B1 (no) 2002-08-12
NO964487D0 (no) 1996-10-22
RO118714B1 (ro) 2003-09-30
GR3031043T3 (en) 1999-12-31
FI120401B (fi) 2009-10-15

Similar Documents

Publication Publication Date Title
IS1844B (is) Rúmvönd aðferð til framleiðslu á kirnisleifahliðstæðum og salisýlatsalt af þeim
DK0980289T3 (da) Fremgangsmåde til fremstilling af carboxylsyresalte og nyttige katalysatorer i en sådan fremgangsmåde
FI970680L (fi) Menetelmä polyhydroksilakaanihapon talteenottamiseksi
FI945451L (fi) Makeutusaineina käytettäviä yhdisteitä sekä menetelmä niiden valmistamiseksi
MX165375B (es) Metodo para elaborar un articulo microporoso
DK474684A (da) 1-benzylaminoalkylpyrrolidinoner, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse
FI942923A7 (fi) Propeenihappojohdannaiset
DK0734382T3 (da) Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåder til deres fremstilling
NO883960L (no) Arylcyklobutenylamidoalkensyrer og salter derav.
IT1208566B (it) Procedimento e dispositivo per fissare elementi di supporto, di collegamento o di articolazione apannelli di polistirolo espanso.
FI963050L (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
FI945510L (fi) Klavulaanihapon diamiinisuolat
DK431888D0 (da) Angioplastikkateter og fremgangsmaade til brugen af det angioplastikkateter og fremgangsmaade til brugen af det
FI973287L (fi) Klavulaanihapposuoloja
DK240989A (da) 2-halogen-4,5-difluorbenzoesyre-forbindelser og fremgangsmaader til fremstilling deraf samt fremgangsmaade til fremstilling af 1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyreestere
DK39789D0 (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre
DK39689D0 (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre og n-phosphonmethyliminodieddikesyrechlorid
FI954786L (fi) Menetelmä aminometaanifosfonihapon valmistamiseksi
DK1023279T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf
DK165444C (da) Meta- og para-isopropenyl-alfa,alfa-dimethylbenzylamin og syreadditionssalte deraf samt fremgangsmaader til fremstilling deraf
DK0546906T3 (da) Ny fremgangsmåde til fremstilling af 4-amino-5-hexensyre
DK133790A (da) Mekanisme og fremgangsmaade til vaeskefyldning af en naesehule samt anvendelse af mekanismen
DK188786A (da) Fremgangsmaade til fremstilling af 2-(4-isobutylphenyl)-propiohydroxaminsyre
DK382284A (da) Fremgangsmaade til fremstilling af 7-acylamino-3-hydroxy-cephem-4-carboxylsyrer og 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylsyrer